$85 Million Settlement reached in Whistleblower case with Johnson & Johnson

Settlement Amount: 

A settlement has been reached in a whistleblower class action lawsuit brought against Johnson & Johnson who is accused of misbranding its drug Natrecor, used to treat heart failure.

Johnson & Johnson has agreed to pay the government a criminal fine of $85 million.

Filed in July 2011, the complaint alleges Johnson & Johnson was misbranding the medicine because its labeling lacked adequate directions for use.

If you have a similar case please fill out the form below or email mail@whistleblowerinstitute.com or call: 619-452–1218


If you or someone you know experienced a similar situation or any other wrongdoing within a corporation you should contact mail@whistleblowerinstitute.com or call: 619-452–1218

Go to top